The Carlyle Group L.P. Stock News

MSCI's broadest index of Asia-Pacific shares outside Japan fell 0.6 per cent on Monday morning, while Wall Street sharply retreated on Friday.

Asian shares got off to a shaky start as the relentless spread of the coronavirus made investors question their optimism .Brent crude futures fell 62 cents to $40.40 a barrel, while U.S. crude lost 60

HDFC Bank is planning to raise ₹10,000 - 13,000 crore via share sales in India and issuance of ADRs.US-based global investment firm Carlyle Group Inc will buy 20% stake in Piramal Pharma for around

Ultimate Software and Kronos Incorporated today announced the Equity at Work Council.

Buyout giant KKR is considering adding National Australia Bank's MLC Wealth to its Australian private equity portfolio.

"We have a very differentiated business and are a very global business."

Diversified company Piramal Enterprises on Saturday said that it will integrate its pharma businesses into Piramal Pharma.

The transaction, which is one of the largest private equity deals in the Indian pharmaceutical industry, values the pharma business at an enterprise value of $2.8 billion and will have an upside compo

The transaction values the pharma business at an enterprise value (EV) of $2.77 billion, with an upside component of up to $360 million depending on the company’s FY21 performance.

The capital raise will accelerate Piramal Pharma's organic and inorganic growth plans, the Ajay Piramal-led Piramal Enterprises and Carlyle Group said in the joint statement.

The 20% stake sale values Piramals pharma business at Rs 20,000 crore.

The estimated equity capital investment for Carlyle's 20 per cent stake in Piramal Pharma would amount to around USD 490 million.

Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.